These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34229158)

  • 1. Long-term seizure outcomes in patients with anti-Leucine-rich glioma-inactivated 1 encephalitis.
    Lin N; Liu Q; Chen J; Jin L; Huang Y; Lu Q; Guan H
    Epilepsy Behav; 2021 Sep; 122():108159. PubMed ID: 34229158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study.
    Muñoz-Lopetegi A; Guasp M; Prades L; Martínez-Hernández E; Rosa-Justícia M; Patricio V; Armangué T; Rami L; Borràs R; Castro-Fornieles J; Compte A; Gaig C; Santamaria J; Dalmau J;
    Lancet Neurol; 2024 Mar; 23(3):256-266. PubMed ID: 38365378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term evolution and prognostic factors of epilepsy in limbic encephalitis with LGI1 antibodies.
    Guery D; Cousyn L; Navarro V; Picard G; Rogemond V; Bani-Sadr A; Shor N; Joubert B; Muñiz-Castrillo S; Honnorat J; Rheims S
    J Neurol; 2022 Sep; 269(9):5061-5069. PubMed ID: 35595970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroencephalographic findings in antileucine-rich glioma-inactivated 1 (LGI1) autoimmune encephalitis: A systematic review.
    Roberto KT; Espiritu AI; Fernandez MLL; Gutierrez JC
    Epilepsy Behav; 2020 Nov; 112():107462. PubMed ID: 32971385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
    Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC
    Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of seizure semiology and semiquantitative FDG-PET analysis of anti-LGI1 encephalitis.
    Li TR; Zhang YD; Wang Q; Shao XQ; Lv RJ
    CNS Neurosci Ther; 2021 Oct; 27(10):1173-1181. PubMed ID: 34291554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faciobrachial motor seizures: A more apt description?
    Muthusamy S; Foroush NC; Seneviratne U
    Epilepsy Behav Rep; 2021; 16():100476. PubMed ID: 34505053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
    Huang X; Fan C; Gao L; Li L; Ye J; Shen H
    J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seizure underreporting in LGI1 and CASPR2 antibody encephalitis.
    Baumgartner T; Pitsch J; Olaciregui-Dague K; Hoppe C; Racz A; Rüber T; Becker A; von Wrede R; Surges R
    Epilepsia; 2022 Sep; 63(9):e100-e105. PubMed ID: 35735209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seizure semiology and predictors of outcomes in Chinese patients with glutamic acid decarboxylase antibody-associated neurological syndrome.
    Lin N; Bai L; Liu Q; Chen J; Ren H; Guan H; Lu Q
    BMC Neurol; 2023 Apr; 23(1):149. PubMed ID: 37041500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizure Semiology in Antibody-Associated Autoimmune Encephalitis.
    Kaaden T; Madlener M; Angstwurm K; Bien CG; Bogarin Y; Doppler K; Finke A; Gerner ST; Reimann G; Häusler M; Handreka R; Hellwig K; Kaufmann M; Kellinghaus C; Koertvelyessy P; Kraft A; Lewerenz J; Menge T; Paliantonis A; von Podewils F; Prüss H; Rauer S; Ringelstein M; Rostásy K; Schirotzek I; Schwabe J; Sokolowski P; Suesse M; Sühs KW; Surges R; Tauber SC; Thaler F; Bergh FT; Urbanek C; Wandinger KP; Wildemann B; Mues S; Zettl U; Leypoldt F; Melzer N; Geis C; Malter M; Kunze A;
    Neurol Neuroimmunol Neuroinflamm; 2022 Nov; 9(6):. PubMed ID: 36266054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ictal electroencephalography (EEG) activity and cerebral blood flow dynamics as potential pathological indicators: a case of anti-leucine-rich glioma-inactivated 1 protein (LGI1) encephalitis].
    Ishibashi H; Neshige S; Aoki S; Ueno H; Iida K; Maruyama H
    Rinsho Shinkeigaku; 2020 Nov; 60(11):778-785. PubMed ID: 33115994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seizure characteristics, treatment, and outcome in autoimmune synaptic encephalitis: A long-term study.
    Zhang W; Wang X; Shao N; Ma R; Meng H
    Epilepsy Behav; 2019 May; 94():198-203. PubMed ID: 30974347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Symptomatic Seizures and Risk of Seizure Recurrence in Patients with Anti-NMDAR, Anti-LGI1, and Anti-GABA
    Cui D; Feng J; Yang M; Dong Y; Lian Y
    Neurol Sci; 2024 Apr; 45(4):1609-1617. PubMed ID: 37940748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-leucine-rich Glioma Inactivated-1 Encephalitis Associated with Essential Thrombocythemia.
    Yuan X; Man X; Zhang J; Sun J; Liang J; Ma H; Tao S; Guo D; Liu L
    Intern Med; 2020; 59(2):271-275. PubMed ID: 31941873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Electroencephalographic Features of the Seizures in Neuronal Surface Antibody-Associated Autoimmune Encephalitis.
    Wang Y; Yu Y; Hu Y; Li Y; Song F; Wang Y
    Front Neurol; 2020; 11():280. PubMed ID: 32431657
    [No Abstract]   [Full Text] [Related]  

  • 17. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.
    Irani SR; Stagg CJ; Schott JM; Rosenthal CR; Schneider SA; Pettingill P; Pettingill R; Waters P; Thomas A; Voets NL; Cardoso MJ; Cash DM; Manning EN; Lang B; Smith SJ; Vincent A; Johnson MR
    Brain; 2013 Oct; 136(Pt 10):3151-62. PubMed ID: 24014519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and long-term outcomes of seizures associated with autoimmune encephalitis: A follow-up study in East China.
    Yao L; Yue W; Xunyi W; Jianhong W; Guoxing Z; Zhen H
    J Clin Neurosci; 2019 Oct; 68():73-79. PubMed ID: 31331752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis.
    Chen C; Wang X; Zhang C; Cui T; Shi WX; Guan HZ; Ren HT; Shao XQ
    Epilepsy Behav; 2017 Dec; 77():90-95. PubMed ID: 29050866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analysis of 9 cases with Anti-leucine-rich glioma inactivated 1 protein antibody associated limbic encephalitis].
    Zhang YX; Yang HL; Wu YY; Wang CC; Gao XY; Shi YY; Liu HQ; Huang Y; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2017 May; 97(17):1295-1298. PubMed ID: 28482428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.